Cybin Inc. to Present at Oppenheimer Healthcare Conference

Ticker: HELP · Form: 6-K · Filed: Mar 18, 2024 · CIK: 1833141

Cybin INC. 6-K Filing Summary
FieldDetail
CompanyCybin INC. (HELP)
Form Type6-K
Filed DateMar 18, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: conference-presentation, healthcare, news-release

TL;DR

Cybin presenting at Oppenheimer Healthcare Conf tomorrow, March 19th.

AI Summary

On March 18, 2024, Cybin Inc. filed a Form 6-K report. This filing includes a news release dated March 18, 2024, announcing that Cybin will be presenting at the 2024 Oppenheimer & Co. Inc. 19th Annual Healthcare Conference. The conference presentation is scheduled for March 19, 2024.

Why It Matters

This presentation provides Cybin with a platform to share its latest developments and strategies with investors and industry professionals, potentially influencing its stock performance and future partnerships.

Risk Assessment

Risk Level: low — This filing is a routine report of a company presentation and does not contain significant new financial or operational information that would inherently increase risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K filing serves as a Report of Foreign Private Issuer and includes a news release announcing Cybin Inc.'s participation in the 2024 Oppenheimer & Co. Inc. 19th Annual Healthcare Conference.

When is Cybin Inc. scheduled to present at the Oppenheimer Healthcare Conference?

Cybin Inc. is scheduled to present at the 2024 Oppenheimer & Co. Inc. 19th Annual Healthcare Conference on March 19, 2024.

Who signed this Form 6-K filing on behalf of Cybin Inc.?

Doug Drysdale, Chief Executive Officer of Cybin Inc., signed the Form 6-K filing.

What is Cybin Inc.'s principal executive office address?

Cybin Inc.'s principal executive office is located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.

What is the SEC file number for Cybin Inc.?

Cybin Inc.'s SEC file number is 001-40673.

Filing Stats: 147 words · 1 min read · ~1 pages · Grade level 10.1 · Accepted 2024-03-18 14:49:28

Filing Documents

From the Filing

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2024. Commission File Number 001-40673 Cybin Inc. (Exact Name of Registrant as Specified in Charter) 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CYBIN INC. (Registrant) Date March 18, 2024 By s Doug Drysdale Name Doug Drysdale Title Chief Executive Officer EXHIBIT INDEX 99.1 News Release dated March 18, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing